Drug‐Loaded Nanogel for Efficient Orchestration of Cell Death Pathways by Intramitochondrial Disulfide Polymerization
Abstract
Chemotherapy using a nanoscaled drug delivery system is an effective cancer therapy, but its high drug concentration often causes drug resistance in cancer cells and normal cell damage. Combination therapy involving two or more different cell signaling pathways can be a powerful tool to overcome the limitations of chemotherapy. Herein, this article presents nanogel (NG)‐mediated co‐delivery of a chemodrug camptothecin (CPT) and mitochondria‐targeting monomer (MT monomer) for efficient activation of two modes of the programmed cell death pathway (apoptosis and necroptosis) and synergistic enhancement of cancer therapy. CPT and the monomer are incorporated together into the redox‐degradable polymeric NGs for release in response to the intracellular glutathione. The MT monomer is shown to undergo reactive oxygen species (ROS)‐triggered disulfide polymerization inside the cancerous mitochondria in cooperation with the chemotherapeutic CPT elevating the intracellular ROS level. The CPT/monomer interconnection in cell death mechanisms for mitochondrial dysfunction and enhanced cell death is evidenced by a series of cell analyses showing ROS generation, mitochondria damage, impacts on (non)cancerous or drug‐resistant cells, and cell death modes. The presented work provides beneficial insights for utilizing combination therapy to facilitate a desired cell death mechanism and developing a novel nanosystem for more efficacious cancer treatment.Keywords
Funding Information
- National Research Foundation of Korea
This publication has 41 references indexed in Scilit:
- Evolution of Mitochondria as Signaling OrganellesCell Metabolism, 2015
- Noncovalent Polymer‐Gatekeeper in Mesoporous Silica Nanoparticles as a Targeted Drug Delivery PlatformAdvanced Functional Materials, 2014
- Mitochondria‐Targeted Cancer Therapy Using a Light‐Up Probe with Aggregation‐Induced‐Emission CharacteristicsAngewandte Chemie International Edition, 2014
- Mitochondrial Delivery of Doxorubicin via Triphenylphosphine Modification for Overcoming Drug Resistance in MDA-MB-435/DOX CellsMolecular Pharmaceutics, 2014
- Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell linesBMC Cancer, 2013
- Polymer nanogels: A versatile nanoscopic drug delivery platformAdvanced Drug Delivery Reviews, 2012
- Surface-Functionalizable Polymer Nanogels with Facile Hydrophobic Guest Encapsulation CapabilitiesJournal of the American Chemical Society, 2010
- Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline TreatmentJournal of Clinical Oncology, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007